Bianco, A.; Pagliaro, R.; Schiattarella, A.; Mariniello, D.F.; D’Agnano, V.; Cianci, R.; Nigro, E.; Daniele, A.; Scialò, F.; Perrotta, F.
Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines 2025, 13, 1817.
https://doi.org/10.3390/biomedicines13081817
AMA Style
Bianco A, Pagliaro R, Schiattarella A, Mariniello DF, D’Agnano V, Cianci R, Nigro E, Daniele A, Scialò F, Perrotta F.
Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines. 2025; 13(8):1817.
https://doi.org/10.3390/biomedicines13081817
Chicago/Turabian Style
Bianco, Andrea, Raffaella Pagliaro, Angela Schiattarella, Domenica Francesca Mariniello, Vito D’Agnano, Roberta Cianci, Ersilia Nigro, Aurora Daniele, Filippo Scialò, and Fabio Perrotta.
2025. "Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management" Biomedicines 13, no. 8: 1817.
https://doi.org/10.3390/biomedicines13081817
APA Style
Bianco, A., Pagliaro, R., Schiattarella, A., Mariniello, D. F., D’Agnano, V., Cianci, R., Nigro, E., Daniele, A., Scialò, F., & Perrotta, F.
(2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines, 13(8), 1817.
https://doi.org/10.3390/biomedicines13081817
